# PP-37 — Implement disease-related protein clustering

## 1. Objective

Explore whether protein features and PPI context reveal coherent groups associated with curated disease annotations.

## 2. Scope and dependencies

PP-20 protein master; PP-29 graph features; PP-33 fused features; PP-34 annotations/labels.

Related plans: [PP-20](../PP-20%20Generate%20protein%20master%20and%20PPI%20Parquet%20datasets/plan.md) · [PP-29](../PP-29%20Implement%20PPI%20network%20analytics%20and%20community%20detection/plan.md) · [PP-33](../PP-33%20Integrate%20structure%2C%20sequence%20and%20PPI%20features/plan.md) · [PP-34](../PP-34%20Prepare%20multi-label%20protein%20function%20prediction%20dataset/plan.md) · [PP-36](../PP-36%20Implement%20combined%20feature%20and%20graph-based%20prediction/plan.md) · [PP-38](../PP-38%20Evaluate%20models%20and%20analyze%20prediction%20performance/plan.md) · [PP-39](../PP-39%20Implement%20protein%20search%20and%20detail%20REST%20APIs/plan.md). These plans define the data/API handoffs; preserve their identifiers, versions, and error semantics.

## 3. Step-by-step implementation and to-do

### Step 1 — Define disease association data and research question

Clarify whether clustering is exploratory or disease-label-informed; do not present clusters as causal disease mechanisms.

**To-do**
- [ ] Identify approved disease annotation source and licensing
- [ ] Define disease association fields and evidence quality
- [ ] Choose unsupervised versus semi-supervised analysis scope
- [ ] Define leakage safeguards if disease labels are used for evaluation

### Step 2 — Prepare clustering feature matrix

Select protein feature groups and handle scale, missing modalities, and outliers.

**To-do**
- [ ] Join selected PP-33 features and PP-29 graph descriptors
- [ ] Define scaling and dimensionality reduction fitted on analysis cohort
- [ ] Record missingness and protein coverage
- [ ] Freeze feature version and analysis cohort

### Step 3 — Implement and compare clustering methods

Run suitable algorithms and evaluate cluster structure without overclaiming biological meaning.

**To-do**
- [ ] Implement baseline methods such as K-means and/or hierarchical clustering
- [ ] Evaluate density-based method if cluster shapes warrant it
- [ ] Tune parameters using unsupervised criteria and stability checks
- [ ] Save cluster assignments and model parameters

### Step 4 — Interpret and publish findings

Compare clusters with independent disease annotations and document uncertainty.

**To-do**
- [ ] Calculate silhouette/stability and cluster-size diagnostics
- [ ] Enrich clusters with disease/GO terms using independent annotations
- [ ] Identify representative proteins and network neighborhoods
- [ ] Publish exploratory report and limitations for PP-38

## 4. Deliverables

- Working analysis/API capability and documented contract.
- Reproducible outputs, representative examples, and version/provenance metadata.
- Automated tests, operational guidance, and known limitations.

## 5. Acceptance criteria

- [ ] All step-level to-dos are complete.
- [ ] Inputs, outputs, score semantics, and version metadata are documented.
- [ ] Invalid, missing, and unavailable data/backends are handled explicitly.
- [ ] Resource limits and observability are in place where applicable.
- [ ] Unit and integration tests pass on representative fixtures.

## 6. Testing strategy

- **Unit:** business rules, validation, mapping, and error handling.
- **Integration:** relevant database, graph, vector, model, and REST boundaries.
- **Quality:** reproducibility, referential integrity, metric correctness, and provenance.
- **Performance:** query latency, response size, and bounded resource use.

## 7. Cross-task handoff

- **Upstream:** PP-20 protein master; PP-29 graph features; PP-33 fused features; PP-34 annotations/labels.
- **Consumers / coordination:** PP-20, PP-29, PP-33, PP-34, PP-36, PP-38, PP-39
- **Contract rule:** publish API/schema versions, sample requests/responses, evaluation or quality results, and limitations. Coordinate breaking changes with all linked plans.

## 8. Completion notes

Record data/model/backend versions, commands, test results, sample outputs, and deviations.
